HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Karin Lundberg Selected Research

Phosphopyruvate Hydratase (Enolase)

5/2013Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
6/2011Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis.
12/2010Periodontitis in RA-the citrullinated enolase connection.
9/2010Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
12/2009Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.
10/2008Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
8/2008Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
1/2005Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Karin Lundberg Research Topics

Disease

26Rheumatoid Arthritis
12/2015 - 09/2004
5Inflammation
01/2015 - 01/2005
5Arthritis (Polyarthritis)
10/2014 - 01/2005
1Psoriatic Arthritis
12/2015
1Necrosis
12/2015
1Osteoarthritis
12/2015
1Chronic Obstructive Pulmonary Disease (COPD)
01/2015
1Metrorrhagia (Spotting)
01/2012
1Joint Diseases (Joint Disease)
06/2011
1Pain (Aches)
06/2011
1Periodontitis
12/2010
1Down Syndrome (Down's Syndrome)
05/2010
1Autoimmune Diseases (Autoimmune Disease)
01/2010
1Bacterial Infections (Bacterial Infection)
10/2008
1Multiple Sclerosis
01/2008
1Experimental Arthritis
01/2005

Drug/Important Bio-Agent (IBA)

15AntibodiesIBA
12/2015 - 01/2005
13Proteins (Proteins, Gene)IBA
01/2015 - 01/2005
8PeptidesIBA
01/2015 - 01/2008
8Phosphopyruvate Hydratase (Enolase)IBA
05/2013 - 01/2005
5AutoantigensIBA
12/2015 - 01/2006
5Fibrinogen (Factor I)FDA Link
01/2015 - 01/2010
5AntigensIBA
01/2015 - 01/2005
5AutoantibodiesIBA
10/2014 - 01/2005
4CitrullineIBA
01/2015 - 01/2005
4acetyl 4-aminosalicylic acidIBA
01/2014 - 01/2010
4Collagen Type II (Type II Collagen)IBA
05/2013 - 09/2004
2Arginine (L-Arginine)FDA Link
12/2015 - 01/2008
2VimentinIBA
01/2015 - 05/2013
2protein-arginine deiminaseIBA
01/2015 - 09/2010
1DNA (Deoxyribonucleic Acid)IBA
12/2015
1EnzymesIBA
01/2015
1homocitrullineIBA
01/2015
1Methotrexate (Mexate)FDA LinkGeneric
01/2015
1Immunoglobulin G (IgG)IBA
01/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012
1C-Reactive ProteinIBA
06/2011
1Antigen-Antibody Complex (Immune Complex)IBA
01/2010
1HLA-DRB1 antigen (HLA DRB1)IBA
12/2009
1HLA-DR Antigens (HLA-DR)IBA
01/2006
1serum P-component (CIt)IBA
01/2005
1Serum AlbuminIBA
01/2005